CClinicalTrials.gg
Status unknownNCT03731858Updated Jan 9, 2019

HbA1c in Intracytoplasmic Sperm Injection

An observational study in Infertility, sponsored by Aljazeera Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-09.

Sponsored by Aljazeera Hospital · Observational

The sponsor has not verified this record recently (last verified Nov 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
400
Ages
20 Years to 42 Years
Sex
Female
01

Study summary

ICSI has increased nowadays for treating cases of longstanding infertility . HbA1c has an important value in evaluating glucose level in blood

Read the detailed description
  • The level of HbA1c in blood denotesnthe glycemic control over the past 3 months . Its regulation is very important in human reproductive life
02

Conditions studied

  • Infertility

Browse trials for

03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's planned enrollment of 400 is above the median of 200 across 714 observational studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Aljazeera Hospital is the lead sponsor of 63 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

-Any lady with infertilty and has a recurrent ICSI trials

Inclusion criteria

  • females with infertility from 20 to 42 years old

Exclusion criteria

Exclusion Criteria:

  • females with age below 20 or above 42 years
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
400 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. the number of ladies who will get pregnant

    the ladies who will become pregnant after ICSI

    Time frame: within one year

07

Study locations

1 of 1 sites recruiting
  • Algazeerah and Kasralainy hospital
    Giza, Egypt
    • Mahmoud Alalfy, master · Contact · mahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact · +201014005959
    • Mahmoud Alalfy, master · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03731858
Lead sponsor
Aljazeera Hospital
Responsible party
Sponsor
First posted
Nov 6, 2018
Start date
Nov 10, 2018
Primary completion
Jul 1, 2019 (estimated)
Completion
Jul 15, 2019 (estimated)
Last update
Jan 9, 2019

Study contacts

Mahmoud Alalfy, PhD
Contact
mahmoudalalfy@ymail.com
01002611058
Mahmoud Alalfy, PhD
study chair · Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion